Trial Profile
A Phase II Study of Irinotecan (Camptosar), Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2014
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Cisplatin; Irinotecan
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 28 Nov 2005 New trial record.